$1.410
-0.085 (-6.00%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Kiora Pharmaceuticals Inc (KPRX) Moving Averages Convergence Divergence (MACD) indicator is -0.26, suggesting KPRX is Strong sell.
Kiora Pharmaceuticals Inc (KPRX) 20-Day simple moving average is 2.11, while Kiora Pharmaceuticals Inc (KPRX) share price is $—, making it Sell.
Kiora Pharmaceuticals Inc (KPRX) 60-Day simple moving average is 2.43, while Kiora Pharmaceuticals Inc (KPRX) share price is $—, making it Sell.
Technical Analysis for KPRX
AI Technical KPRXAs of 2026-11-07, the technical board for Kiora Pharmaceuticals Inc (KPRX) reads strong sell: 2 indicators are flashing buy, 9 are indicating sell, and 2 are neutral. Price at $1.41 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 22.076, MACD stands at -0.263 (Sell), Stochastic %K stands at 5.346 (Buy), Stochastic %D stands at 9.121 and CCI stands at -139.25 (Buy).
KPRX trades below the 60-day SMA (2.43) and below the 200-day SMA (2.40). Immediate resistance sits at Classic R1 2.46, then R2 3.10. Support sits at Classic S1 1.29, then S2 0.76.
Kiora Pharmaceuticals Inc (KPRX) Support & Resistance Level
Kiora Pharmaceuticals Inc (KPRX) Technical Indicators
2026-11-07
| Name | Value |
|---|---|
| RSI_14 | 22.076 |
| STOCHk_14_3_3 | 5.346 |
| STOCHd_14_3_3 | 9.121 |
| CCI_20 | -139.250 |
| AO_5_34 | -0.690 |
| MOM_10 | -0.850 |
| MACD_12_26_9 | -0.263 |
Kiora Pharmaceuticals Inc (KPRX) Relative Strength Index (RSI_14) is 22.076, creating a Buy signal.
Kiora Pharmaceuticals Inc (KPRX) Stochastic %K is 5.346, creating a Buy signal.
Kiora Pharmaceuticals Inc (KPRX) Stochastic %D is 9.121, creating a Buy signal.
Kiora Pharmaceuticals Inc (KPRX) CCI_20 is -139.250, creating a Buy signal.
Kiora Pharmaceuticals Inc (KPRX) Awesome Oscillator (AO) is -0.690, creating a Sell signal.
Kiora Pharmaceuticals Inc (KPRX) Momentum (MOM) is -0.850, creating a Sell signal.
Kiora Pharmaceuticals Inc (KPRX) Moving Average Convergence Divergence (MACD) is -0.263, creating a Sell signal.
Kiora Pharmaceuticals Inc (KPRX) Moving Average
2026-11-07
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 1.591 | Sell |
| MA_10 | 1.814 | Sell |
| MA_20 | 2.106 | Sell |
| MA_60 | 2.434 | Sell |
| MA_200 | 2.397 | Sell |
| MA_250 | 2.334 | Sell |
Kiora Pharmaceuticals Inc (KPRX) 5-Day simple moving average is 1.591, while Kiora Pharmaceuticals Inc (KPRX) share price is $, making it a Sell.
Kiora Pharmaceuticals Inc (KPRX) 10-Day simple moving average is 1.814, while Kiora Pharmaceuticals Inc (KPRX) share price is $, making it a Sell.
Kiora Pharmaceuticals Inc (KPRX) 20-Day simple moving average is 2.106, while Kiora Pharmaceuticals Inc (KPRX) share price is $, making it a Sell.
Kiora Pharmaceuticals Inc (KPRX) 60-Day simple moving average is 2.434, while Kiora Pharmaceuticals Inc (KPRX) share price is $, making it a Sell.
Kiora Pharmaceuticals Inc (KPRX) 200-Day simple moving average is 2.397, while Kiora Pharmaceuticals Inc (KPRX) share price is $, making it a Sell.
Kiora Pharmaceuticals Inc (KPRX) 250-Day simple moving average is 2.334, while Kiora Pharmaceuticals Inc (KPRX) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.